Published in:
01-02-2013 | Commentary
A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia
Published in: Critical Care | Issue 1/2013
Login to get accessAbstract
The optimal length of antimicrobial therapy has not been extensively studied for a great majority of infections and, in critically ill patients affected by ventilator-associated pneumonia, is a persisting and unsolved issue confronting clinicians. The integration of biomarkers, clinical judgment, and microbiologic eradication might help to define a shorter duration for some ventilator-associated pneumonia episodes due to non-fermenting Gram-negative bacilli, but until these strategies are implemented in clinical practice for individualizing antibiotic treatment, a short-course duration does not seem to tailor a long benefit.